A comparison of the expression level of HPGDS with the mutation status of IDH1 showed that HPGDS was more highly expressed in IDH1 wild-type gliomas, especially grade 2 and 4 gliomas. The gene discussed is HPGDS; the disease is central nervous system cancer.